MedTrace Logo

In Vivo Detection of Circulating Clots in Patients With Thromboembolism

NCT05301348 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-02-19

No results posted yet for this study

Summary

Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.

Conditions

  • Thromboembolism

Interventions

DEVICE

Photoacoustic Flow Cytometry

Detection of circulating blood clots

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Sanjeeva Onteddu, MD · University of Arkansas

  • Jonathan A Young · University of Arkansas

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-26
Primary Completion
2026-12-31
Completion
2027-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05301348 on ClinicalTrials.gov